Altavista Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $1.26M | Buy |
5,604
+4
| +0.1% | +$844 | 0.25% | 70 |
|
|
2021
Q3 | $1.19M | Buy |
5,600
+4
| +0.1% | +$921 | 0.26% | 69 |
|
|
2021
Q2 | $1.36M | Sell |
5,596
-22
| -0.4% | -$5.41K | 0.3% | 65 |
|
|
2021
Q1 | $1.4M | Sell |
5,618
-6
| -0.1% | -$1.43K | 0.34% | 61 |
|
|
2020
Q4 | $1.29M | Buy |
5,624
+3
| +0.1% | +$692 | 0.33% | 59 |
|
|
2020
Q3 | $1.43M | Sell |
5,621
-17
| -0.3% | -$4.21K | 0.39% | 54 |
|
|
2020
Q2 | $1.33M | Buy |
5,638
+3
| +0.1% | +$684 | 0.39% | 56 |
|
|
2020
Q1 | $1.14M | Sell |
5,635
-47
| -0.8% | -$10.3K | 0.39% | 53 |
|
|
2019
Q4 | $1.37M | Buy |
5,682
+3
| +0.1% | +$661 | 0.41% | 56 |
|
|
2019
Q3 | $1.1M | Sell |
5,679
-157
| -3% | -$30.1K | 0.34% | 62 |
|
|
2019
Q2 | $1.07M | Sell |
5,836
-18
| -0.3% | -$3.22K | 0.34% | 64 |
|
|
2019
Q1 | $1.11M | Buy |
5,854
+3
| +0.1% | +$573 | 0.39% | 60 |
|
|
2018
Q4 | $1.14M | Buy |
5,851
+3
| +0.1% | +$585 | 0.47% | 60 |
|
|
2018
Q3 | $1.21M | Sell |
5,848
-97
| -2% | -$19.1K | 0.45% | 59 |
|
|
2018
Q2 | $1.1M | Buy |
5,945
+3
| +0.1% | +$531 | 0.44% | 61 |
|
|
2018
Q1 | $1.01M | Sell |
5,942
-97
| -2% | -$17.8K | 0.43% | 62 |
|
|
2017
Q4 | $1.05M | Buy |
6,039
+2,268
| +60% | +$401K | 0.44% | 61 |
|
|
2017
Q3 | $703K | Sell |
3,771
-98
| -3% | -$17.4K | 0.33% | 69 |
|
|
2017
Q2 | $666K | Sell |
3,869
-159
| -4% | -$25.9K | 0.33% | 70 |
|
|
2017
Q1 | $661K | Buy |
4,028
+43
| +1% | +$7.14K | 0.33% | 68 |
|
|
2016
Q4 | $583K | Buy |
3,985
+10
| +0.3% | +$1.5K | 0.32% | 70 |
|
|
2016
Q3 | $663K | Sell |
3,975
-14
| -0.4% | -$2.37K | 0.36% | 65 |
|
|
2016
Q2 | $607K | Buy |
3,989
+9
| +0.2% | +$1.4K | 0.33% | 68 |
|
|
2016
Q1 | $597K | Buy |
3,980
+125
| +3% | +$18.6K | 0.34% | 62 |
|
|
2015
Q4 | $626K | Sell |
3,855
-79
| -2% | -$12.4K | 0.37% | 61 |
|
|
2015
Q3 | $544K | Sell |
3,934
-75
| -2% | -$11.8K | 0.36% | 66 |
|
|
2015
Q2 | $615K | Sell |
4,009
-140
| -3% | -$22.4K | 0.38% | 60 |
|
|
2015
Q1 | $663K | Hold |
4,149
| – | – | 0.41% | 57 |
|
|
2014
Q4 | $663K | Sell |
4,149
-821
| -17% | -$128K | 0.41% | 59 |
|
|
2014
Q3 | $698K | Sell |
4,970
-50
| -1% | -$6.53K | 0.45% | 59 |
|
|
2014
Q2 | $594K | Buy |
5,020
+73
| +1% | +$8.45K | 0.37% | 63 |
|
|
2014
Q1 | $610K | Sell |
4,947
-3,610
| -42% | -$438K | 0.37% | 75 |
|
|
2013
Q4 | $976K | Sell |
8,557
-559
| -6% | -$63.6K | 0.6% | 50 |
|
|
2013
Q3 | $1.02M | Sell |
9,116
-219
| -2% | -$23.7K | 0.66% | 48 |
|
|
2013
Q2 | $921K | Buy |
+9,335
| New | +$969K | 0.62% | 47 |
|
Other funds holding AMGN
Altavista Wealth Management's AMGN Position: Q4 2021 in Review
Altavista Wealth Management increased its Amgen (AMGN) stake by 0.07% in Q4 2021, buying an estimated $844 and bringing the position to 5,604 shares worth $1.26M. The position accounts for 0.25% of the portfolio, ranked #70.
Altavista Wealth Management first reported a position in AMGN in Q2 2013 and has held it in 35 quarters since. The position peaked at $1.43M in Q3 2020. 2,294 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.
- Altavista Wealth Management held 5,604 shares of Amgen worth $1.26M as of Q4 2021.
- Altavista Wealth Management bought 4 Amgen shares in Q4 2021, an estimated $844.
- Amgen made up 0.25% of Altavista Wealth Management's portfolio in Q4 2021, its #70 holding.
- Altavista Wealth Management first reported a position in Amgen in Q2 2013 and has held it in 35 quarters since.
- Altavista Wealth Management's Amgen position peaked at $1.43M in Q3 2020.
- 2,294 funds tracked by Wall St. Rank held Amgen as of Q4 2021.
Based on Altavista Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.